Antibody-based therapies for COVID-19: Can Europe move faster?

Kazatchkine, Michel D; Goldman, Michel; Vincent, Jean-Louis

Kazatchkine, Michel D; Goldman, Michel; Vincent, Jean-Louis.

Kazatchkine MD; Global Health Center, Graduate Institute, Geneva, Switzerland.
Goldman M; I3h Institute, Université libre de Bruxelles, Brussels, Belgium.
Vincent JL; Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.

PLoS Med ; 17(5): e1003127, 2020 05.

Article in English | MEDLINE | ID: covidwho-175732

ABSTRACT

ABSTRACT

Michel Goldman and colleagues call on the European medical and scientific community to coordinate efforts on immunotherapy-based approaches to coronavirus.

Subject(s)

Antibodies, Viral/therapeutic use; Betacoronavirus/immunology; Coronavirus Infections/therapy; Pneumonia, Viral/therapy; Antibodies, Viral/immunology; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Coronavirus Infections/diagnosis; Coronavirus Infections/immunology; European Union; Humans; Immunization, Passive; Pandemics; Pneumonia, Viral/diagnosis; Pneumonia, Viral/immunology; SARS-CoV-2; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus / Antibodies, Viral Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: PLoS Med Journal subject: Medicine Year: 2020 Document Type: Article Affiliation country: Journal.pmed.1003127

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google